Molecular Partners Ag (MOLN) Capital Expenditures (2020 - 2026)
Molecular Partners Ag (MOLN) reported Capital Expenditures of -$49,255 for Q3 2026, compared with -$1.4 million a year earlier.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Molecular Partners Ag's Capital Expenditures came in at $1.36 million, up 80.4% year-over-year; for FY2025, it came in at $861,176, up 7.5% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $801,375 in FY2024 (+25.2%), $640,230 in FY2023 (-48.1%), $1.23 million in FY2022 (+20.8%) and $1.02 million in FY2021 (-34.0%).
- Five-year quarterly Capital Expenditures spans a low of -$1.4 million in Q3 2025 and a high of $1.85 million in Q4 2022.
- The high point for year-over-year Capital Expenditures in five years was Q4 2021 (growth of 482.1%); the low point was Q2 2022 (a decline of 67.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Molecular Partners Ag | 125.16 Mn | -243.89 Mn | - | -49,255.46 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -49,255.46 |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | -498,288.24 |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | 479,914.37 |
| Mar 31, 2024 | -139,773.24 |
| Dec 31, 2023 | 960,506.01 |
| Sep 30, 2023 | -523,054.48 |
| Jun 30, 2023 | 278,043.89 |
| Mar 31, 2023 | -70,275.57 |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | -1.07 Mn |
| Jun 30, 2022 | 803,638.79 |
| Mar 31, 2022 | -376,817.32 |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | -1.09 Mn |
| Dec 31, 2020 | 2.91 Mn |
API Access
Molecular Partners Ag Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();